BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5002719)

  • 1. Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyroptropin releasing factor (TRF) in patients with pituitary tumors.
    Faglia G; Beck Peccoz P; Ambrosi B; Ferrari C; Neri V
    J Clin Endocrinol Metab; 1971 Dec; 33(6):999-1002. PubMed ID: 5002719
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of the radioimmunoassay of serum thyrotrophin in man.
    Hershman JM; Pittman JA
    Ann Intern Med; 1971 Apr; 74(4):481-90. PubMed ID: 4994544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)].
    Silvestrini F; Liuzzi A; Chiodini PG; Cattabeni A; Botalla L
    Folia Endocrinol; 1973 Oct; 26(5):398-406. PubMed ID: 4203133
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone.
    Patel YC; Burger HG
    J Clin Endocrinol Metab; 1973 Aug; 37(2):190-6. PubMed ID: 4352630
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stimulation of TSH secfetion by TRF load in hypothalamic and pituitary diseases].
    Pickardt CR; Geiger W; Fahlbusch R; Scriba PC
    Klin Wochenschr; 1972 Jan; 50(1):42-52. PubMed ID: 4621744
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic thyrotropin releasing factor as a test of pituitary thyrotropin reserve.
    Fleischer N; Lorente M; Kirkland J; Kirkland R; Clayton G; Calderon M
    J Clin Endocrinol Metab; 1972 Apr; 34(4):617-24. PubMed ID: 4335101
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of a synthetic thyrotrophin releasing hormone (TRH) in normal and endocrinopathic subjects.
    Faglia G; Beck-Peccoz P; Ambrosi B; Ferrari C; Travaglini P
    Acta Endocrinol (Copenh); 1972 Oct; 71(2):209-25. PubMed ID: 4627179
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of synthetic TRH on human prolactin (HPr) secretion].
    Kato Y; Ogo S; Chihara K; Imura H
    Nihon Naibunpi Gakkai Zasshi; 1973 Sep; 49(9):1215-22. PubMed ID: 4201607
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct evaluation of pituitary thyrotopin reserve utilizing synthetic thyrotopin releasing hormone.
    Haigler ED; Pittman JA; Hershman JM; Baugh CM
    J Clin Endocrinol Metab; 1971 Oct; 33(4):573-81. PubMed ID: 4999252
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tertiary hypothyroidism in idiopathic and acquired adeno-pituitary insufficiency].
    Pavía C; Webb S; Ferrer I; Martín MR; Valls C; Palou A
    Med Clin (Barc); 1983 Dec; 81(18):801-4. PubMed ID: 6418995
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of synthetic thyrotropin-releasing factor (TRF) on pituitary TSH secretion in man.
    Sakoda M; Otsuki M; Hiroshige N; Kanao K; Yagi A
    Endocrinol Jpn; 1970 Dec; 17(6):541-9. PubMed ID: 4996357
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of TRF in the study of pituitary reserve of TSH].
    Cantalamessa L; Reschini E; Giustina G; Miedico D; Valentini F; Beretta F
    Folia Endocrinol; 1973 Feb; 26(1):57-70. PubMed ID: 4633898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proceedings: Anomalies in the regulation of the secretion of corticotropin in chromophobe adenomas].
    Lucas C; Olivier C; Jaquet P; Vague J
    Ann Endocrinol (Paris); 1974; 35(5):595. PubMed ID: 4377076
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyrotropin: alpha- and beta-subunits of thyrotropin, and prolactin responses to four-hour constant infusions of thyrotropin-releasing hormone in normal subjects and patients with pituitary-thyroid disorders.
    Chan V; Wang C; Yeung RT
    J Clin Endocrinol Metab; 1979 Jul; 49(1):127-31. PubMed ID: 109462
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma TSH values in normal subjects and patients with various endocrine disorders].
    Hiroshige N; Kanao K; Inoue M; Sakoda M; Otsuki M
    Nihon Naibunpi Gakkai Zasshi; 1972 Nov; 48(8):569-77. PubMed ID: 4674391
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders.
    Faglia G; Beck-Peccoz P; Ferrari C; Ambrosi B; Spada A; Travaglini P; Paracchi S
    J Clin Endocrinol Metab; 1973 Oct; 37(4):595-601. PubMed ID: 4200495
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolactin secretion in sixty-five patients with galactorrhea.
    Tolis G; Somma M; Van Campenhout J; Friesen H
    Am J Obstet Gynecol; 1974 Jan; 118(1):91-101. PubMed ID: 4202979
    [No Abstract]   [Full Text] [Related]  

  • 19. The application of synthetic LRF and TRF in a combined function test in patients with pituitary tumors.
    zur Mühlen A von ; Köbberling J; Halves E; Scharphuis T
    Acta Endocrinol Suppl (Copenh); 1973; 173():94. PubMed ID: 4199196
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of synthetic thyrotrophin-releasing factor on pituitary TSH secretion in normal subjects and patients with hypothalamic-pituitary disorders.
    Otsuki M; Mori H; Baba S; Hiroshige N
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):233-49. PubMed ID: 4199384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.